Acasti Pharma Inc KOL Event Transcript
Good afternoon, and welcome to the Acasti Pharma KOL event. (Operator Instructions) As a reminder, this call is being recorded and a replay will made available on the Acasti website following the conclusion of the event.
I'd now like to turn the call over to Prashant Kohli, Chief Executive Officer for Acasti Pharma. Please go ahead, Prashant.
Thank you, operator, and good afternoon, everyone. Welcome to our virtual webinar on our lead asset, GTX-104 in novel IV formulation of nimodipine and its potential to disrupt the standard of care dosage form in the rare disease and aneurysmal subarachnoid hemorrhage.
Before introducing our speakers, I remind everyone that on today's call, we will be making forward-looking statements, which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements. For more information, please visit our website.
I'm joined on today's call by 2 very distinguished speakers, Dr. Taylor Kimberly, is Chief of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |